Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000033

CEO sold 1,000 shares at $16.17 ($16,174)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal CEO 2024-06-13 Sale 10b5-1 −1,000 $16.17 $16,174 336,375 D
Open-market sales · 1,000 sh · avg $16.17 · $16,174
Loading xslF345X05/wk-form4_1718397122.xml…